Search

everythinglearnresearchcommunity

for

Search:↓

Aging skin causes inflammation that affects the whole body.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Hidradenitis suppurativa is linked to various diseases like obesity, depression, arthritis, and Crohn's disease, but often occurs alone.

New therapies are being developed that target integrin pathways to treat various diseases.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Interleukin-6 may play a role in causing alopecia areata.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

These gene variations are not linked to alopecia areata in Egyptians.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.